12 Panel Drug Test Cup with BUP - Identify Diagnostics CLIA Waived

The Identify Diagnostics 12 Panel Drug Test Cup has emerged as a reliable and convenient solution for drug testing in various settings. This innovative urine screening device uses lateral flow immunoassay technology to detect drug metabolites in urine samples, making it an essential tool for drug screening in the workplace, rehabilitation centers, and other scenarios where drug testing is required. With CLIA Waiver and OTC Clearance from the FDA, the Identify Diagnostics 12 Panel Drug Test Cup has gained credibility for its accuracy and ease of use.

Understanding Lateral Flow Immunoassay Technology

The key feature of the Identify Diagnostics 12 Panel Drug Test Cup lies in its use of lateral flow immunoassay technology, a diagnostic tool widely recognized for its simplicity, rapidity, and reliability. This technology utilizes the principles of immunochromatography, where a sample is combined with labeled antibodies that bind specifically to the target analytes, which in this case are drug metabolites. The mixture then migrates along a porous membrane, and if the target metabolites are present, they form complexes with the labeled antibodies, resulting in a visible signal at the test line. The intensity of this signal is directly proportional to the concentration of the drug metabolites, enabling the test to provide both qualitative and semi-quantitative results.

Advantages of the Identify Diagnostics 12 Panel Drug Test Cup

1) Comprehensive Testing: The Identify Diagnostics 12 Panel Drug Test Cup is capable of detecting multiple drug metabolites simultaneously, making it a versatile and efficient tool for drug testing. The 12-panel test covers a wide range of substances, including AMP - Amphetamines 1000 ng/ml, BAR - Barbiturates 300 ng/ml, BUP - Buprenorphine 10 ng/ml, BZO - Benzodiazepines 300 ng/ml, COC - Cocaine 300 ng/ml, MDMA - Ecstasy 500 ng/ml, MET - Methamphetamines 1000 ng/ml, MOP - Opiates / Morphine 300 ng/ml, MTD - Methadone 300 ng/ml, OXY - Oxycodone 100 ng/ml, PCP - Phencyclidine 25 ng/ml, THC - Cannabinoid (Marijuana) 50 ng/ml.

2) Rapid Results: The test provides results within just 5 minutes, allowing for quick decisions and actions based on the outcome. This rapid turnaround time is crucial in various settings, such as pre-employment screening, where time-sensitive decisions are often required.

3) Ease of Use: The Identify Diagnostics 12 Panel Drug Test Cup is designed for user-friendly operation, requiring minimal training or expertise. The self-contained cup design eliminates the need for additional equipment, making the test suitable for both professional and home office settings.

4) CLIA Waived and FDA OTC Cleared: The test's Clinical Laboratory Improvement Amendments (CLIA) Waiver and Over-The-Counter (OTC) clearance from the Food and Drug Administration (FDA) ensure that it meets stringent quality and performance standards.

Conclusion

The Identify Diagnostics 12 Panel Drug Test Cup provides a comprehensive, efficient, and user-friendly solution for drug testing, utilizing lateral flow immunoassay technology to deliver accurate results. With its CLIA Waiver and OTC Clearance from the FDA, this test has become an essential tool for various drug screening applications. Its ability to detect multiple drug metabolites within a short period makes it a valuable asset for employers, rehabilitation centers, and other organizations that require reliable drug testing.

The best drug test cups with accurate results and the most reliable customer service come from us here at Identify. We are a leading family of brands in the industry by offering top quality urine screening devices in the USA for over 15 years. Identify Diagnostics drug tests are in use nationwide by attorney law office firms, boarding schools and college educational institutions, dentist offices, drug court testing environments, employers, employment staffing agencies, family law specialists, family practice doctors, government drug test cup programs, home office drug testing, hospitals, insurance companies, law enforcement drug testing, medical laboratory research facilities, national rehabilitation facilities, pain management physicians, parole offices, prisons / jails / correctional facilities, professional sports teams / athletic academies, recovery sober living houses, religious institutions and shelters, substance abuse clinics, US probation offices, youth juvenile detention centers.